Literature DB >> 12721754

Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.

Fumiyuki Yamasaki1, Seiji Hama, Hiroyuki Yoshioka, Yoshinori Kajiwara, Kaita Yahara, Kazuhiko Sugiyama, Yuji Heike, Kazunori Arita, Kaoru Kurisu.   

Abstract

OBJECTIVE: The mechanisms involved in the cell cycle and cell death remain unresolved despite much investigation. Staurosporine induces cell death and G1 or G2/M arrest in a dose-dependent manner, but the mechanisms remain unknown.
METHODS: In the present study an adenovirus vector expressing p16 or p21 genes in human glioma cell lines was used to examine cell cycle regulation and cell death induced by staurosporine.
RESULTS: A low concentration (</=10 n M) of staurosporine induced G1 arrest of U251MG cells, whereas a high concentration (>/=30 n M) induced G2/M arrest and finally induced apoptosis via a caspase-3-activated pathway from both the G2/M and G1 phases. However, pRb was dephosphorylated and cdc2 was inhibited at both the low and the high concentrations of staurosporine, indicating that the mechanisms of cell cycle regulation are not simply p53-Rb- or cdc2-dependent pathways.
CONCLUSIONS: Forced G1 arrest by transfection with p16 or p21 genes did not alter the rate of staurosporine-induced cell death. This implies that an unknown pathway of apoptosis occurs from the G1 phase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721754     DOI: 10.1007/s00280-002-0562-z

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  9 in total

1.  Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cells.

Authors:  Dong-feng Han; Jun-xia Zhang; Wen-jin Wei; Tao Tao; Qi Hu; Ying-yi Wang; Xie-feng Wang; Ning Liu; Yong-ping You
Journal:  Tumour Biol       Date:  2015-01-08

2.  Possible involvement of calcium channels and plasma membrane receptors on Staurosporine-induced neurite outgrowth.

Authors:  Hossein Zhaleh; Mehri Azadbakht; Ali Bidmeshki Pour
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

3.  Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors.

Authors:  Mugdha N Harmalkar; Neelam V Shirsat
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

4.  Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.

Authors:  Takeo Goji; Kazuhiko Takahara; Manabu Negishi; Hironori Katoh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

5.  Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor.

Authors:  Alexander H Stegh; Cameron Brennan; John A Mahoney; Kristin L Forloney; Harry T Jenq; Janina P Luciano; Alexei Protopopov; Lynda Chin; Ronald A Depinho
Journal:  Genes Dev       Date:  2010-09-13       Impact factor: 11.361

6.  Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.

Authors:  Mollianne McGahren Murray; Tuyen Bui; Michelle Smith; Rozita Bagheri-Yarmand; Hannah Wingate; Kelly K Hunt; Khandan Keyomarsi
Journal:  Carcinogenesis       Date:  2013-05-30       Impact factor: 4.944

7.  Effect of Pentoxifylline on Staurosporine-Induced Neurite Elongation in PC12 Cells.

Authors:  Loghman Diojan; Hossein Zhaleh; Mehri Azadbakht; Ali Bidmeshkipour; Ehsan Khodamoradi
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

8.  p16 Gene transfer increases cell killing with abnormal nucleation after ionising radiation in glioma cells.

Authors:  S Hama; S Matsuura; H Tauchi; F Yamasaki; Y Kajiwara; K Arita; H Yoshioka; Y Heike; K Mandai; K Kurisu
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

9.  ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays.

Authors:  Camilo Guzmán; Manish Bagga; Amanpreet Kaur; Jukka Westermarck; Daniel Abankwa
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.